1 SAM Kelly , CD Summerbell , A Brynes , et al. (2007) Wholegrain cereals for coronary heart disease. The Cochrane Database of Systematic Reviews 2007 issue .
5 RC Masters , AD Liese , SM Haffner , et al. (2010) Whole and refined grain intakes are related to inflammatory protein concentrations in human plasma. J Nutr 140, 587–594.
6 AJ Gaskins , SL Mumford , AJ Rovner , et al. (2010) Whole grains are associated with serum concentrations of high sensitivity C-reactive protein among premenopausal women. J Nutr 140, 1669–1676.
8 L Qi , RM Van Dam , SM Liu , et al. (2006) Whole-grain, bran, and cereal fiber intakes and markers of systemic inflammation in diabetic women. Diabetes Care 29, 207–211.
10 R Estruch , E Sacanella , E Badia , et al. (2004) Different effects of red wine and gin consumption on inflammatory biomarkers of atherosclerosis: a prospective randomized crossover trial – effects of wine on inflammatory markers. Atherosclerosis 175, 117–123.
11 K Esposito , R Marfella , M Ciotola , et al. (2004) Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome – a randomized trial. JAMA 292, 1440–1446.
13 AM Lampi , T Nurmi , V Ollilainen , et al. (2008) Tocopherols and tocotrienols in wheat genotypes in the HEALTHGRAIN diversity screen. J Agric Food Chem 56, 9716–9721.
17 NM Anson , R van den Berg , R Havenaar , et al. (2008) Ferulic acid from aleurone determines the antioxidant potency of wheat grain (Triticum aestivum L.). J Agric Food Chem 56, 5589–5594.
18 LP Liu , L Zubik , FW Collins , et al. (2004) The antiatherogenic potential of oat phenolic compounds. Atherosclerosis 175, 39–49.
20 L Enright & J Slavin (2010) No effect of 14 day consumption of whole grain diet compared to refined grain diet on antioxidant measures in healthy, young subjects: a pilot study. Nutr J 9, 12–19.
23 P Tighe , G Duthie , N Vaughan , et al. (2010) Effect of increased consumption of whole-grain foods on blood pressure and other cardiovascular risk markers in healthy middle-aged persons: a randomized controlled trial. Am J Clin Nutr 92, 733–740.
25 RK Price , EM Keaveney , LL Hamill , et al. (2010) Consumption of wheat aleurone-rich foods increases fasting plasma betaine and modestly decreases fasting homocysteine and LDL-cholesterol in adults. J Nutr 140, 2153–2157.
26 FJ Zhao , YH Su , SJ Dunham , et al. (2009) Variation in mineral micronutrient concentrations in grain of wheat lines of diverse origin. J Cereal Sci 49, 290–295.
27 JL Stroud , FJ Zhao , P Buchner , et al. (2010) Impacts of sulphur nutrition on selenium and molybdenum concentrations in wheat grain. J Cereal Sci 52, 111–113.
28 JR Howarth , S Parmar , J Jones , et al. (2008) Co-ordinated expression of amino acid metabolism in response to N and S deficiency during wheat grain filling. J Exp Bot 59, 3675–3689.
29 L Li , PR Shewry & JL Ward (2008) Phenolic acids in wheat varieties in the HEALTHGRAIN diversity screen. J Agric Food Chem 56, 9732–9739.
30 RK Price , RW Welch , AM Lee-Manion , et al. (2008) Total phenolics and antioxidant potential in plasma and urine of humans after consumption of wheat bran. Cereal Chem 85, 152–157.
31 IFF Benzie & JJ Strain (1996) The ferric reducing ability of plasma (FRAP) as a measure of ‘antioxidant power’: the FRAP assay. Anal Biochem 239, 70–76.
33 Y Matsui , S Nakamura , N Kondou , et al. (2007) Liquid chromatography-electrospray ionization-tandem mass spectrometry for simultaneous analysis of chlorogenic acids and their metabolites in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 858, 96–105.
34 Y Konishi , ZH Zhao & M Shimizu (2006) Phenolic acids are absorbed from the rat stomach with different absorption rates. J Agric Food Chem 54, 7539–7543.
35 PM Ridker (2003) Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107, 363–369.
36 SS Bassuk , N Rifai & PM Ridker (2004) High-sensitivity C-reactive protein: clinical importance. Curr Probl Cardiol 29, 439–493.
37 PM Ridker , J MacFadyen , P Libby , et al. (2010) Relation of baseline high-sensitivity C-reactive protein level to cardiovascular outcomes with rosuvastatin in the justification for use of statins in prevention: an intervention trial evaluating rosuvastatin (JUPITER). Am J Cardiol 106, 204–209.
38 LP He , XY Tang , WH Ling , et al. (2010) Early C-reactive protein in the prediction of long-term outcomes after acute coronary syndromes: a meta-analysis of longitudinal studies. Heart 96, 339–346.
40 J Danesh , JG Wheeler , GM Hirschfield , et al. (2004) C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350, 1387–1397.
41 PM Ridker , JE Buring , J Shih , et al. (1998) Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 98, 731–733.
42 M Hanefeld , N Marx , A Pfutzner , et al. (2007) Anti-inflammatory effects of pioglitazone and/or sinivastatin in high cardiovascular risk patients with elevated high sensitivity C-reactive protein – the PIOSTAT study. J Am Coll Cardiol 49, 290–297.
44 S Kinlay (2007) Low-density lipoprotein-dependent and -independent effects of cholesterol-lowering therapies on C-reactive protein – a meta-analysis. J Am Coll Cardiol 49, 2003–2009.
45 E Zakynthinos & N Pappa (2009) Inflammatory biomarkers in coronary artery disease. J Cardiol 53, 317–333.
46 L Papatheodorou & N Weiss (2007) Vascular oxidant stress and inflammation in hyperhomocysteinemia. Antioxid Redox Signal 9, 1941–1958.
47 MF Abdelmalek , SO Sanderson , P Angulo , et al. (2009) Betaine for nonalcoholic fatty liver disease: results of a randomized placebo-controlled trial. Hepatology 50, 1818–1826.
48 G Targher (2006) Relationship between high-sensitivity C-reactive protein levels and liver histology in subjects with non-alcoholic fatty liver disease. J Hepatol 45, 879–881.
49 NM Anson , R van den Berg , R Havenaar , et al. (2009) Bioavailability of ferulic acid is determined by its bioaccessibility. J Cereal Sci 49, 296–300.
50 SM Kern , RN Bennett , FA Mellon , et al. (2003) Absorption of hydroxycinnamates in humans after high-bran cereal consumption. J Agric Food Chem 51, 6050–6055.
51 P Vitaglione , A Napolitano & V Fogliano (2008) Cereal dietary fibre: a natural functional ingredient to deliver phenolic compounds into the gut. Trends Food Sci Technol 19, 451–463.
52 A Costabile , A Klinder , F Fava , et al. (2008) Whole-grain wheat breakfast cereal has a prebiotic effect on the human gut microbiota: a double-blind, placebo-controlled, crossover study. Br J Nutr 99, 110–120.
55 R Giacco , G Clemente , D Cipriano , et al. (2010) Effects of the regular consumption of wholemeal wheat foods on cardiovascular risk factors in healthy people. Nutr Metab Cardiovasc Dis 20, 186–194.